Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Universe Pharmaceuticals (UPC) Inventory (2020 - 2024)

Historic Inventory for Universe Pharmaceuticals (UPC) over the last 6 years, with Q3 2025 value amounting to $2489.7 billion.

  • Universe Pharmaceuticals' Inventory rose 32347984.52% to $2489.7 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2489.7 billion, marking a year-over-year increase of 32347984.52%. This contributed to the annual value of $2489.7 billion for FY2025, which is 32347984.52% up from last year.
  • Latest data reveals that Universe Pharmaceuticals reported Inventory of $2489.7 billion as of Q3 2025, which was up 32347984.52% from -$769.9 million recorded in Q3 2024.
  • In the past 5 years, Universe Pharmaceuticals' Inventory ranged from a high of $2489.7 billion in Q3 2025 and a low of -$769.9 million during Q3 2024
  • Moreover, its 5-year median value for Inventory was $288339.5 (2023), whereas its average is $311.1 billion.
  • As far as peak fluctuations go, Universe Pharmaceuticals' Inventory crashed by 780527.64% in 2023, and later surged by 32347984.52% in 2025.
  • Quarter analysis of 5 years shows Universe Pharmaceuticals' Inventory stood at $2.7 million in 2021, then decreased by 19.42% to $2.2 million in 2022, then crashed by 7805.28% to -$170.0 million in 2023, then crashed by 352.85% to -$769.9 million in 2024, then surged by 323479.85% to $2489.7 billion in 2025.
  • Its Inventory was $2489.7 billion in Q3 2025, compared to -$769.9 million in Q3 2024 and $368960.0 in Q1 2024.